AdvanDx
Rapid diagnostics for critical infections. Improving antibiotic decisions and patient outcomes..
Launch date
Employees
Market cap
-
Enterprise valuation
$48—72m (Dealroom.co estimates Apr 2014.)
Woburn Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$5.0m | Series B | ||
$5.0m | Series B | ||
$5.0m | Series B | ||
$15.0m | Series C | ||
$8.0m | Series C | ||
N/A | $4.0m | Debt | |
N/A | $3.5m | Debt | |
N/A | $2.2m | Early VC | |
$12.0m | Early VC | ||
N/A | $2.5m | Debt | |
N/A | Acquisition | ||
Total Funding | $52.2m |